Global Drug Policy will be debated at the united nations in 2016.
The voice of physicians will be heard.
825
Physicians Signed
 
Target: 1500 by January 2015
2,500 by march 2015 | 5,000 by 2016
Join Now
UNGASS
Board
Naloxone
Shadow
In The News
Ukrainian drug addicts dying due to treatment ban, says UN
United Nations envoy says those on substitution therapy in annexed Crimea could face death after Russia made it illegal.
India rejects Gilead's Hepatitis C drug patent request
India's patent office has rejected an application from U.S.-based Gilead Sciences Inc for its hepatitis C drug Sovaldi, paving the way for local drugmakers to launch cheaper generic versions of the $1,000-a-pill medicine.
Virginia Berridge on the history of drug control, Rolleston and the 'British System'
Virginia Berridge, professor of History at the London School of Hygiene and Tropical Medicine, explains how the shaping of the UK drug control in the 20th Century was influenced by the US control system, and how the fact that many of the drug users were middle class and doctors created a disparity on policies.
Publications
Preventing fatal overdoses: A systematic review of the effectiveness of take-home naloxone This paper considers how naloxone — an effective antidote that can reverse opioid intoxication — combined with training in first aid for coping with an overdose for people who are not health professionals can help save lives.
Do benzodiazepines increase the risk of dementia? A Canadian case-control study published has reinforced previous concerns of a link between benzodiazepines and dementia, suggesting a more permanent impact.
Pharmacological treatment of attention deficit hyperactivity disorder with co-morbid drug dependence Drug dependence is frequent in patients with attention deficit hyperactivity disorder (ADHD). Nevertheless, the efficacy and safety of pharmacological treatments in this population are unclear.